421 related articles for article (PubMed ID: 20559016)
1. CRTH2 and D-type prostanoid receptor antagonists as novel therapeutic agents for inflammatory diseases.
Schuligoi R; Sturm E; Luschnig P; Konya V; Philipose S; Sedej M; Waldhoer M; Peskar BA; Heinemann A
Pharmacology; 2010; 85(6):372-82. PubMed ID: 20559016
[TBL] [Abstract][Full Text] [Related]
2. Antagonists of the prostaglandin D2 receptor CRTH2.
Pettipher R; Hansel TT
Drug News Perspect; 2008; 21(6):317-22. PubMed ID: 18836589
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic profile of OC000459, a potent, selective, and orally active D prostanoid receptor 2 antagonist that inhibits mast cell-dependent activation of T helper 2 lymphocytes and eosinophils.
Pettipher R; Vinall SL; Xue L; Speight G; Townsend ER; Gazi L; Whelan CJ; Armer RE; Payton MA; Hunter MG
J Pharmacol Exp Ther; 2012 Feb; 340(2):473-82. PubMed ID: 22106101
[TBL] [Abstract][Full Text] [Related]
4. Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemoattractant receptor-homologous molecule expressed on Th2 cells/DP2.
Yoshimura-Uchiyama C; Iikura M; Yamaguchi M; Nagase H; Ishii A; Matsushima K; Yamamoto K; Shichijo M; Bacon KB; Hirai K
Clin Exp Allergy; 2004 Aug; 34(8):1283-90. PubMed ID: 15298571
[TBL] [Abstract][Full Text] [Related]
5. CRTH2 mediates the activation of human Th2 cells in response to PGD(2) released from IgE/anti-IgE treated nasal polyp tissue.
Pérez-Novo CA; Holtappels G; Vinall SL; Xue L; Zhang N; Bachert C; Pettipher R
Allergy; 2010 Mar; 65(3):304-10. PubMed ID: 19839971
[TBL] [Abstract][Full Text] [Related]
6. The opposing role of two prostaglandin D2 receptors, DP and CRTH2, in human eosinophil migration.
Chiba T; Ueki S; Ito W; Kato H; Kamada R; Takeda M; Kayaba H; Furue M; Chihara J
Ann Allergy Asthma Immunol; 2011 Jun; 106(6):511-7. PubMed ID: 21624751
[TBL] [Abstract][Full Text] [Related]
7. A novel antagonist of prostaglandin D2 blocks the locomotion of eosinophils and basophils.
Royer JF; Schratl P; Carrillo JJ; Jupp R; Barker J; Weyman-Jones C; Beri R; Sargent C; Schmidt JA; Lang-Loidolt D; Heinemann A
Eur J Clin Invest; 2008 Sep; 38(9):663-71. PubMed ID: 18837743
[TBL] [Abstract][Full Text] [Related]
8. Novel function of CRTH2 in preventing apoptosis of human Th2 cells through activation of the phosphatidylinositol 3-kinase pathway.
Xue L; Barrow A; Pettipher R
J Immunol; 2009 Jun; 182(12):7580-6. PubMed ID: 19494281
[TBL] [Abstract][Full Text] [Related]
9. Possible novel receptor for PGD2 on human bronchial epithelial cells.
Chiba T; Kanda A; Ueki S; Ito W; Yamaguchi K; Kamada Y; Takeda M; Tanigai T; Oyamada H; Kayaba H; Chihara J
Int Arch Allergy Immunol; 2007; 143 Suppl 1():23-7. PubMed ID: 17541272
[TBL] [Abstract][Full Text] [Related]
10. Antagonism of the prostaglandin D2 receptor CRTH2 attenuates asthma pathology in mouse eosinophilic airway inflammation.
Uller L; Mathiesen JM; Alenmyr L; Korsgren M; Ulven T; Högberg T; Andersson G; Persson CG; Kostenis E
Respir Res; 2007 Feb; 8(1):16. PubMed ID: 17328802
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin H2 induces the migration of human eosinophils through the chemoattractant receptor homologous molecule of Th2 cells, CRTH2.
Schuligoi R; Sedej M; Waldhoer M; Vukoja A; Sturm EM; Lippe IT; Peskar BA; Heinemann A
J Leukoc Biol; 2009 Jan; 85(1):136-45. PubMed ID: 18835884
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of the 4-aminotetrahydroquinoline derivatives, selective chemoattractant receptor-homologous molecule expressed on T helper 2 cell antagonists, on eosinophil migration induced by prostaglandin D2.
Mimura H; Ikemura T; Kotera O; Sawada M; Tashiro S; Fuse E; Ueno K; Manabe H; Ohshima E; Karasawa A; Miyaji H
J Pharmacol Exp Ther; 2005 Jul; 314(1):244-51. PubMed ID: 15798001
[TBL] [Abstract][Full Text] [Related]
13. CRTH2 is a prominent effector in contact hypersensitivity-induced neutrophil inflammation.
Takeshita K; Yamasaki T; Nagao K; Sugimoto H; Shichijo M; Gantner F; Bacon KB
Int Immunol; 2004 Jul; 16(7):947-59. PubMed ID: 15173122
[TBL] [Abstract][Full Text] [Related]
14. D-type prostanoid receptor enhances the signaling of chemoattractant receptor-homologous molecule expressed on T(H)2 cells.
Sedej M; Schröder R; Bell K; Platzer W; Vukoja A; Kostenis E; Heinemann A; Waldhoer M
J Allergy Clin Immunol; 2012 Feb; 129(2):492-500, 500.e1-9. PubMed ID: 21930295
[TBL] [Abstract][Full Text] [Related]
15. Emerging roles of DP and CRTH2 in allergic inflammation.
Kostenis E; Ulven T
Trends Mol Med; 2006 Apr; 12(4):148-58. PubMed ID: 16545607
[TBL] [Abstract][Full Text] [Related]
16. Cutting edge: chemoattractant receptor-homologous molecule expressed on Th2 cells plays a restricting role on IL-5 production and eosinophil recruitment.
Chevalier E; Stock J; Fisher T; Dupont M; Fric M; Fargeau H; Leport M; Soler S; Fabien S; Pruniaux MP; Fink M; Bertrand CP; McNeish J; Li B
J Immunol; 2005 Aug; 175(4):2056-60. PubMed ID: 16081770
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin D2 induces IL-8 and GM-CSF by bronchial epithelial cells in a CRTH2-independent pathway.
Chiba T; Kanda A; Ueki S; Ito W; Kamada Y; Oyamada H; Saito N; Kayaba H; Chihara J
Int Arch Allergy Immunol; 2006; 141(3):300-7. PubMed ID: 16940740
[TBL] [Abstract][Full Text] [Related]
18. A prostaglandin D2 receptor antagonist modifies experimental asthma in sheep.
Shichijo M; Arimura A; Hirano Y; Yasui K; Suzuki N; Deguchi M; Abraham WM
Clin Exp Allergy; 2009 Sep; 39(9):1404-14. PubMed ID: 19486034
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic efficacy of AM156, a novel prostanoid DP2 receptor antagonist, in murine models of allergic rhinitis and house dust mite-induced pulmonary inflammation.
Stebbins KJ; Broadhead AR; Correa LD; Scott JM; Truong YP; Stearns BA; Hutchinson JH; Prasit P; Evans JF; Lorrain DS
Eur J Pharmacol; 2010 Jul; 638(1-3):142-9. PubMed ID: 20447387
[TBL] [Abstract][Full Text] [Related]
20. Targeting the PGD
Kupczyk M; Kuna P
Drugs; 2017 Aug; 77(12):1281-1294. PubMed ID: 28612233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
